HLX04
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for HLX04, covering 2021-07-01 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC [Phase 3]